Metis Global Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.7M Sell
93,168
-9,644
-9% -$2.25M 0.54% 30
2026
Q1
$25.1M Sell
102,812
-1,309
-1% -$305K 0.62% 24
2025
Q4
$21.5M Sell
104,121
-31,512
-23% -$6.23M 0.51% 26
2025
Q3
$25.1M Sell
135,633
-7,756
-5% -$1.33M 0.59% 24
2025
Q2
$21.9M Sell
143,389
-13,012
-8% -$2M 0.57% 23
2025
Q1
$25.9M Buy
156,401
+15,687
+11% +$2.45M 0.73% 19
2024
Q4
$20.4M Buy
140,714
+1,956
+1% +$303K 0.61% 22
2024
Q3
$22.5M Buy
138,758
+4,283
+3% +$682K 0.7% 21
2024
Q2
$19.7M Buy
134,475
+211
+0.2% +$31.4K 0.67% 22
2024
Q1
$21.2M Buy
134,264
+108
+0.1% +$17.2K 0.77% 22
2023
Q4
$21M Buy
134,156
+20,102
+18% +$3.08M 0.84% 20
2023
Q3
$17.8M Buy
114,054
+8,044
+8% +$1.33M 0.86% 18
2023
Q2
$17.5M Buy
106,010
+1,214
+1% +$196K 0.95% 12
2023
Q1
$16.2M Buy
104,796
+27,859
+36% +$4.5M 1.04% 12
2022
Q4
$13.6M Buy
76,937
+30,728
+66% +$5.31M 1.21% 8
2022
Q3
$7.55M Buy
46,209
+2,273
+5% +$385K 1.22% 9
2022
Q2
$7.8M Buy
43,936
+2,122
+5% +$378K 1.25% 9
2022
Q1
$7.41M Buy
41,814
+18,593
+80% +$3.16M 0.89% 12
2021
Q4
$3.97M Buy
+23,221
New +$3.8M 1.1% 12

Other funds holding JNJ

Metis Global Partners's JNJ Position: Q2 2026 in Review

Metis Global Partners reduced its Johnson & Johnson (JNJ) stake by 9.4% in Q2 2026, selling an estimated $2.25M and leaving 93,168 shares worth $23.7M. The position accounts for 0.54% of the portfolio, ranked #30.

Metis Global Partners first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $25.9M in Q1 2025. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Metis Global Partners held 93,168 shares of Johnson & Johnson worth $23.7M as of Q2 2026.
  • Metis Global Partners sold 9,644 Johnson & Johnson shares in Q2 2026, an estimated $2.25M.
  • Johnson & Johnson made up 0.54% of Metis Global Partners's portfolio in Q2 2026, its #30 holding.
  • Metis Global Partners first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Johnson & Johnson position peaked at $25.9M in Q1 2025.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.